《Asian Journal of Andrology》

作品数:3535被引量:10056H指数:30
导出分析报告
《Asian Journal of Andrology》
主办单位:The Shanghai Institute of Materia Medica, Chinese Academy of Sciences (SIMM);Shanghai Jiao Tong University (SJTU)
最新期次:2024年6期更多>>
发文主题:PROSTATE_CANCERSPERMPROSTATETESTOSTERONEMEN更多>>
发文领域:医药卫生生物学农业科学化学工程更多>>
发文作者:李劲松更多>>
发文机构:中国科学院上海生命科学研究院更多>>
发文基金:国家自然科学基金国家重点基础研究发展计划广东省自然科学基金中国博士后科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Meet Guest Editor
《Asian Journal of Andrology》2024年第6期F0002-F0002,共1页
Urology from 1989,and a specialist in Microsurgery and Experimental surgery from 1993.From May 1995 to February 2005,Prof.Siracusano served as the Assistant in Urology at the Urological Clinic,University of Trieste(Tr...
关键词:SURGERY holds techniques. 
Asian Journal of Andrology EDITORIAL BOARD
《Asian Journal of Andrology》2024年第6期I0001-I0001,共1页
AJA Outstanding Paper Award of 2023
《Asian Journal of Andrology》2024年第6期I0003-I0004,共2页
Inari M Ciccone,Elaine MF Costa,Juliana R Pariz,Thiago A Teixeira,Joel R Drevet,Parviz Gharagozloo,Robert J Aitken,Jorge Hallak.Serum vitamin D content is associated with semen parameters and serum testosterone levels...
关键词:VITAMIN Aitken Outstanding 
2023 AJA Outstanding Reviewer Award
《Asian Journal of Andrology》2024年第6期I0004-I0004,共1页
The continued pursuit of new strategies and new technologies
《Asian Journal of Andrology》2024年第6期547-548,共2页Salvatore Siracusano 
Tis increased inthelastyearstobecome the second leading cause of death in males.!In this context,low-risk and intermediaterisk PCa are the most represented clinical patterns and undoubtedly most subjected to technolog...
关键词:INVASION DIAGNOSIS CLINICAL 
Navigating the evolving diagnostic and therapeutic landscape of low-and intermediate-risk prostate cancer被引量:1
《Asian Journal of Andrology》2024年第6期549-556,共8页Fabio Zattoni Fabio Matrone Roberto Bortolus GianlucaGiannarini 
In this nonsystematic review of the literature,we explored the changing landscape of detection and treatment of low-and intermediate-risk prostate cancer(PCa).Through emphasizing improved cancer assessment with histol...
关键词:intermediate-risk prostate cancer MRI PET prostate cancer radical prostatectomy 
Prostate cancer biology from clinical prognostic low-to intermediate-risk groups:looking up at the multiple patterns tracking the way forward被引量:1
《Asian Journal of Andrology》2024年第6期557-558,共2页Antonio Benito Porcaro 
This opinion focuses on the management of low-and intermediate-risk prostate cancer(PCa)groups,emphasizing the need for additional prognostic factors beyond existing risk categories.Molecular biology and multiparametr...
关键词:INVASION ENDOGENOUS LOOKING 
Prostate cancer:screening and early detection被引量:1
《Asian Journal of Andrology》2024年第6期559-561,共3页Orazio Caffo Antonello Veccia 
Prostate cancer is the second most common cancer in men;therefore,the development of adequate programs of prevention is essential to achieve an early detection of the disease and to reduce the mortality.Over the years...
关键词:DIAGNOSIS MORTALITY PREVENTION 
Molecular diagnostics of prostate cancer:impact of molecular tests被引量:1
《Asian Journal of Andrology》2024年第6期562-566,共5页Eros Azzalini Serena Bonin 
Prostate cancer (PCa) is the second leading cause of cancer-related death among men. Prostate-specific antigen (PSA) testing is used in screening programs for early detection with a consequent reduction of PCa-specifi...
关键词:liquid biomarkers MOLECULAR prostate cancer reflex testing 
PSA as the driving biomarker to manage low-and intermediate-risk prostate cancer patients in clinical practice被引量:1
《Asian Journal of Andrology》2024年第6期567-568,共2页Enrico Ricevuto Celeste Morgani Fabrizia Seri Gemma Bruera 
Prostate cancer risk stratification relies on several clinical factors. Low-risk patients, characterized by T1–T2a stage, Gleason score (GS) ≤6, and prostate-specific antigen (PSA) <10 ng ml−1, exhibit an excellent ...
关键词:patients CLINICAL cancer 
检索报告 对象比较 聚类工具 使用帮助 返回顶部